[PDF][PDF] Possible treatment and strategies for COVID-19: review and assessment.
The coronavirus disease 2019 (COVID-19) is declared as an international emergency in
2020. Its prevalence and fatality rate are rapidly increasing but the medication options are …
2020. Its prevalence and fatality rate are rapidly increasing but the medication options are …
Literature-based review of the drugs used for the treatment of COVID-19
M Venkatasubbaiah, PD Reddy… - … medicine research and …, 2020 - Elsevier
COVID-19 is primarily a respiratory disease caused by a newly discovered SARS-CoV-2
virus and identified in the city of Wuhan, China in December 2019. WHO has declared this …
virus and identified in the city of Wuhan, China in December 2019. WHO has declared this …
Antiviral treatment of COVID-19: a clinical pharmacology narrative review
IGAAP Sri, JE Marzuki, F Angelia, A Siane… - Medical journal of …, 2020 - mji.ui.ac.id
The outbreak of coronavirus disease 2019 (COVID-19) in December 2019 in China, has
become a pandemic in March 2020. Repurposing old and relatively safe drugs becomes an …
become a pandemic in March 2020. Repurposing old and relatively safe drugs becomes an …
[HTML][HTML] An update on current therapeutic drugs treating COVID-19
The current pandemic of coronavirus disease 2019 (COVID-19) caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) has presented unprecedented …
respiratory syndrome coronavirus 2 (SARS-CoV-2) has presented unprecedented …
[HTML][HTML] Emerging pharmacotherapies for COVID-19
R Salvi, P Patankar - Biomedicine & Pharmacotherapy, 2020 - Elsevier
Abstract Novel Corona-virus Disease 2019 (nCOVID 19) is caused by a novel virulent
corona virus and leads to potentially fatal virulent pneumonia and severe respiratory distress …
corona virus and leads to potentially fatal virulent pneumonia and severe respiratory distress …
Antiviral treatment of COVID-19
Currently, there is not any specific effective antiviral treatment for COVID-19. Although most
of the COVID-19 patients have mild or moderate courses, up to 5%-10% can have severe …
of the COVID-19 patients have mild or moderate courses, up to 5%-10% can have severe …
Efficacy of the current investigational drugs for the treatment of COVID-19: a scoping review
To date, there is no final FDA-approved treatment for COVID-19. There are thousands of
studies published on the available treatments for COVID-19 virus in the past year. Therefore …
studies published on the available treatments for COVID-19 virus in the past year. Therefore …
[HTML][HTML] Anti COVID-19 drugs: need for more clinical evidence and global action
Abstract The World Health Organization (WHO) called the outbreak of coronavirus infectious
disease-2019 (COVID-19) a “Public Health Emergency of International Concern”(PHEIC) …
disease-2019 (COVID-19) a “Public Health Emergency of International Concern”(PHEIC) …
Old and re-purposed drugs for the treatment of COVID-19
SS Jean, PR Hsueh - Expert review of anti-infective therapy, 2020 - Taylor & Francis
Introduction: The coronavirus disease 2019 (COVID-19) caused by the novel severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) has developed since December 2019. It …
respiratory syndrome coronavirus 2 (SARS-CoV-2) has developed since December 2019. It …
[HTML][HTML] Current COVID-19 treatments: Rapid review of the literature
Y Dong, A Shamsuddin, H Campbell… - Journal of Global …, 2021 - ncbi.nlm.nih.gov
Background As SARS-CoV-2 continues to spread worldwide, it has already resulted in over
110 million cases and 2.5 million deaths. Currently, there are no effective COVID-19 …
110 million cases and 2.5 million deaths. Currently, there are no effective COVID-19 …